IL112999A0 - Crystalline salts of 2,3,4,5- tetrahydro -1h-3-benzazepine compounds, their preparation and pharmaceutical compositions containing them - Google Patents
Crystalline salts of 2,3,4,5- tetrahydro -1h-3-benzazepine compounds, their preparation and pharmaceutical compositions containing themInfo
- Publication number
- IL112999A0 IL112999A0 IL11299995A IL11299995A IL112999A0 IL 112999 A0 IL112999 A0 IL 112999A0 IL 11299995 A IL11299995 A IL 11299995A IL 11299995 A IL11299995 A IL 11299995A IL 112999 A0 IL112999 A0 IL 112999A0
- Authority
- IL
- Israel
- Prior art keywords
- tetrahydro
- preparation
- pharmaceutical compositions
- compositions containing
- crystalline salts
- Prior art date
Links
- 150000003839 salts Chemical class 0.000 title abstract 2
- MWVMYAWMFTVYED-UHFFFAOYSA-N 2,3,4,5-tetrahydro-1h-3-benzazepine Chemical class C1CNCCC2=CC=CC=C21 MWVMYAWMFTVYED-UHFFFAOYSA-N 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- DIKLCFJDIZFAOM-INIZCTEOSA-N (5s)-5-(5-bromo-2,3-dihydro-1-benzofuran-7-yl)-8-chloro-3-methyl-1,2,4,5-tetrahydro-3-benzazepin-7-ol Chemical class C1N(C)CCC2=CC(Cl)=C(O)C=C2[C@H]1C1=CC(Br)=CC2=C1OCC2 DIKLCFJDIZFAOM-INIZCTEOSA-N 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229940124597 therapeutic agent Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DK31194 | 1994-03-16 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL112999A0 true IL112999A0 (en) | 1995-06-29 |
Family
ID=8092128
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL11299995A IL112999A0 (en) | 1994-03-16 | 1995-03-15 | Crystalline salts of 2,3,4,5- tetrahydro -1h-3-benzazepine compounds, their preparation and pharmaceutical compositions containing them |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US5658899A (da) |
| EP (1) | EP0750616B1 (da) |
| JP (1) | JPH09510222A (da) |
| AT (1) | ATE201680T1 (da) |
| AU (1) | AU1945495A (da) |
| DE (1) | DE69521122T2 (da) |
| DK (1) | DK0750616T3 (da) |
| ES (1) | ES2158094T3 (da) |
| IL (1) | IL112999A0 (da) |
| WO (1) | WO1995025102A1 (da) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6410527B1 (en) * | 1998-03-02 | 2002-06-25 | Schering Corporation | Method of treating obsessive compulsive disorders, somatoform disorders, dissociative disorders, eating disorders, impulse control disorders, and autism |
| DE19853487A1 (de) | 1998-11-19 | 2000-05-25 | Fumapharm Ag Muri | Verwendung von Dialkylfumaraten |
| DE10000577A1 (de) * | 2000-01-10 | 2001-07-26 | Fumapharm Ag Muri | Verwendung von Fumarsäurederivaten zur Behandlung mitochondrialer Krankheiten |
| DE50213989D1 (de) | 2001-01-12 | 2009-12-24 | Biogen Idec Internat Gmbh | Verwendung von fumarsäureamiden |
| UA79248C2 (en) * | 2001-11-09 | 2007-06-11 | Janssen Pharmaceutica Nv | Mandelate salts of substituted tetracyclic tetrahydrofuran derivatives |
| BR0313231A (pt) * | 2002-08-05 | 2007-07-24 | Sandoz Ag | sal e polimorfos de hemifumarato de desloratadina |
| BRPI0410805A (pt) | 2003-09-09 | 2006-06-27 | Fumapharm Ag | uso de derivados do ácido fumárico para tratamento da insuficiência cardìaca e asma |
| SI2653873T1 (sl) | 2007-02-08 | 2022-09-30 | Biogen Ma Inc. | Sestave in načini uporabe za zdravljenje multiple skleroze |
| KR20230084597A (ko) | 2011-09-16 | 2023-06-13 | 퍼시몬 테크놀로지스 코포레이션 | 운송 장치 및 이를 포함하는 처리 장치 |
| ES2914043T3 (es) | 2012-07-12 | 2022-06-07 | Emalex Biosciences Inc | Benzazepinas condensadas para el tratamiento del síndrome de tourette |
| SI3057595T1 (sl) | 2013-10-18 | 2020-09-30 | Emalex Biosciences, Inc. | Spojeni benzazepini za zdravljenje jecljanja |
| KR20240046638A (ko) | 2014-01-21 | 2024-04-09 | 퍼시몬 테크놀로지스 코포레이션 | 기판 이송 진공 플랫폼 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5470850A (en) * | 1992-02-24 | 1995-11-28 | Novo Nordisk A/S | 2,3,4,5-tetrahydro-1H-3-benzazepines |
| DK23392D0 (da) * | 1992-02-24 | 1992-02-24 | Novo Nordisk As | Heterocykliske forbindelser, deres anvendelse og fremstilling |
-
1995
- 1995-03-08 DE DE69521122T patent/DE69521122T2/de not_active Expired - Lifetime
- 1995-03-08 ES ES95912143T patent/ES2158094T3/es not_active Expired - Lifetime
- 1995-03-08 AU AU19454/95A patent/AU1945495A/en not_active Abandoned
- 1995-03-08 WO PCT/DK1995/000106 patent/WO1995025102A1/en active IP Right Grant
- 1995-03-08 DK DK95912143T patent/DK0750616T3/da active
- 1995-03-08 AT AT95912143T patent/ATE201680T1/de not_active IP Right Cessation
- 1995-03-08 EP EP95912143A patent/EP0750616B1/en not_active Expired - Lifetime
- 1995-03-08 JP JP7523785A patent/JPH09510222A/ja active Pending
- 1995-03-14 US US08/404,394 patent/US5658899A/en not_active Expired - Lifetime
- 1995-03-15 IL IL11299995A patent/IL112999A0/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ES2158094T3 (es) | 2001-09-01 |
| ATE201680T1 (de) | 2001-06-15 |
| DE69521122D1 (de) | 2001-07-05 |
| JPH09510222A (ja) | 1997-10-14 |
| EP0750616B1 (en) | 2001-05-30 |
| EP0750616A1 (en) | 1997-01-02 |
| US5658899A (en) | 1997-08-19 |
| WO1995025102A1 (en) | 1995-09-21 |
| DK0750616T3 (da) | 2001-07-23 |
| DE69521122T2 (de) | 2002-03-07 |
| AU1945495A (en) | 1995-10-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUP9900605A3 (en) | Lipopolyamines as transfection agents, preparation and use thereof and pharmaceutical compositions containing them | |
| BG104727A (en) | Pharmaceutical composition of topiramate | |
| BG105564A (en) | Galantamine-containing composition with controlled release | |
| EP0727217A3 (en) | Pharmaceutical and cosmetic compositions containing God-type ellagitannin as an active ingredient | |
| HK1002017A1 (en) | Lyospheres comprising gonadotropin | |
| IL108520A0 (en) | Imidazopyridine derivatives, processes for the preparation thereof, and pharmaceutical compositions containing them | |
| MX9605741A (es) | Clorhidrato cristalino del (r)-(-)-2-{n-[4-(1,1-dioxido-3-oxo-2,3-dihidro-benzisotiazol-2-il)-butil ]-aminometil} cromano. | |
| AP2000001947A0 (en) | Novel crystalline forms of an antiviral benzidazole compound. | |
| HU9602051D0 (en) | Delta12,13-iso-taxol analogs, antineoplastic use and pharmaceutical compositions containing them | |
| HUP0203300A3 (en) | 2,4-diaminopyrimidine compounds useful as immunosuppressants, pharmaceutical compositions containing them and their use | |
| HUP9600256A2 (en) | Substituted diphenyl-sulfonamide endothelin antagonists, pharmaceutical compositions containing the same and their medical uses | |
| IL112999A0 (en) | Crystalline salts of 2,3,4,5- tetrahydro -1h-3-benzazepine compounds, their preparation and pharmaceutical compositions containing them | |
| IL101358A0 (en) | Crystalline tiagabine hydrochloride monohydrate,its preparation and pharmaceutical compositions containing it | |
| GB9424766D0 (en) | Pharmaceutical composition | |
| HUP9900365A2 (hu) | N-Aril-1,2,4-triazolin-5-on-származékok, előállításuk és alkalmazásuk, a vegyületeket hatóanyagként tartalmazó inszekticid, arachnicid és nematocid készítmények | |
| ZA961138B (en) | Solid active ingredient compositions containing hydroxypropylcellulose. | |
| AU8332791A (en) | Oral pharmaceutical compositions containing melatonin | |
| HK1005454A1 (en) | Pure crystalline form of refapentine | |
| IL100458A0 (en) | Pharmaceutical compositions containing antagonists of the quisqualate receptor | |
| HK15695A (en) | Solid oral administration forms containing ifosfamide as active agent | |
| IL109866A0 (en) | Crystalline 3-(4-hexyloxy-1,2,5-thiadiazol-3-yl)-1,2,5,6-tetrahydro-1-methylpyridine (+) l-hydrogentartrate, its preparation and pharmaceutical compositions containing it | |
| GEP20043377B (en) | Pharmaceutical Complex | |
| TW261605B (da) | ||
| HUP9903880A3 (en) | Naphtoquinone-derivatives, process for their preparation, fungicidal, insecticidal and acaricidal compositions, containing them as active ingredient and process for their use | |
| HUP9800032A3 (en) | 3-aryluracil-derivatives, preparation and use thereof, herbicidal compositions containing these compounds and preparation of the latest |